Who
David Zawitz
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Verrica Pharmaceuticals.
In numbers
- Trades disclosed
- 7
- Buys
- 2
- Sells
- 0
- Bought
- $102K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 9 Dec 2024
- Last trade
- 17 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
1 Nov 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Aug 2026filed 18 Aug 2026 | VRCA Verrica PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $30K6,000 at $4.98 | filing |
| 17 Aug 2026filed 18 Aug 2026 | VRCA Verrica PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $30K6,000 at $4.98 | filing |
| 5 Jun 2026filed 9 Jun 2026 | VRCA Verrica Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —171,340 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | VRCA Verrica Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —171,340 at $0.00 | filing |
| 25 Nov 2025filed 25 Nov 2025 | VRCA Verrica Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | —2,500 | filing |
| 25 Nov 2025filed 25 Nov 2025 | VRCA Verrica PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $42K10,000 at $4.24 | filing |
| 9 Dec 2024filed 9 Dec 2024 | VRCA Verrica Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —950,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.